---
title: "NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting | NPCE Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288064810.md"
description: "NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting | NPCE Stock News"
datetime: "2026-05-29T04:05:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288064810.md)
  - [en](https://longbridge.com/en/news/288064810.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288064810.md)
---

# NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting | NPCE Stock News

NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting | NPCE Stock News

### Related Stocks

- [NPCE.US](https://longbridge.com/en/quote/NPCE.US.md)

## Related News & Research

- [NeuroPace says FDA deems epilepsy label expansion filing not approvable in current form](https://longbridge.com/en/news/294110473.md)
- [NeuroPace (NASDAQ:NPCE) Upgraded to "Buy" at Wall Street Zen](https://longbridge.com/en/news/278210429.md)
- [NeuroPace Q1 revenue rises 20%, beats estimates, raises 2026 outlook](https://longbridge.com/en/news/286151243.md)
- [Regulatory Shutdowns Threaten Neuropace’s FDA Approvals and Capital Market Access](https://longbridge.com/en/news/277885506.md)
- [NeuroPace (NPCE) Receives a Buy from Lake Street](https://longbridge.com/en/news/277634966.md)